Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ShalbyNSE:SHALBY +0.70%86 EV-to-EBIT is 22.17 as of Aug. 25, 2026, which is 2% below its 10-year median of 22.70. GuruFocus rates NSE:SHALBY with a GF Score™ of 86/100 and a GF Value™ of ₹261.99 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 476 Healthcare Providers & Services companies, Shalby ranks worse than 67.44% on this metric.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Shalby's Enterprise Value is ₹21,677 Mil.
Shalby's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 was ₹978 Mil. Therefore, Shalby's EV-to-EBIT for today is 22.17.
The historical rank and industry rank for Shalby's EV-to-EBIT or its related term are showing as below:
NSE:SHALBY'
s EV-to-EBIT Range Over the Past 10 Years
Min: -178.88 Med: 22.7 Max: 132.92
Current: 22.17
During the past 13 years, the highest EV-to-EBIT of Shalby was 132.92. The lowest was -178.88. And the median was 22.70.
NSE:SHALBY's EV-to-EBIT is ranked worse than 67.44% of 476
companies
in the Healthcare Providers & Services industry
Industry Median: 15.905
vs NSE:SHALBY: 22.17
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Shalby's Enterprise Value for the quarter that ended in Jun. 2026 was ₹18,893 Mil.
Shalby's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹978 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shalby EV-to-EBIT Related Terms
Shalby EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Shalby's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:SHALBY vs HCA, THC, DVA: EV-to-EBIT Comparison
For the Medical Care Facilities subindustry, Shalby's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shalby EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Shalby's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Shalby's EV-to-EBIT falls into.
Shalby's current Enterprise Value is ₹21,677 Mil.
Shalby's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹978 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shalby (NSE:SHALBY) has a EV-to-EBIT of 22.17 as of Aug. 25, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Shalby and its competitors. This is near median its historical median of 22.70. According to the industry distribution chart, Shalby ranks #321 out of 476 companies in the Healthcare Providers & Services industry, placing it in the top 67.4%.
Is Shalby's EV-to-EBIT too high?
Shalby's current EV-to-EBIT of 22.17 is near median its 10-year median of 22.70. The Healthcare Providers & Services industry median EV-to-EBIT is 15.91. Shalby's value of 22.17 is 39.4% above this industry median. Based on the distribution chart, Shalby ranks #321 out of 476 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Shalby has a GF Score™ of 86/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Shalby's EV-to-EBIT compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Shalby ranks #321 out of 476 companies for EV-to-EBIT. This places Shalby in the lower half of its industry. The industry median EV-to-EBIT is 15.91. Shalby's value of 22.17 is 39.4% above this benchmark. While the company's 10-year median is 22.70 vs. the industry median of 15.91, Shalby has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.91, based on 476 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shalby's current EV-to-EBIT of 22.17 is 39.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Shalby and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shalby's current EV-to-EBIT is 22.17, which is near median its own 10-year median of 22.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shalby stock overvalued right now?
Based on GuruFocus' analysis, Shalby (NSE:SHALBY) is currently considered Possible Value Trap. The stock's GF Value™ is ₹261.99, compared to a current price of ₹154.03 — trading 41.2% below its estimated fair value. The current EV-to-EBIT is 22.17, which is near median its 10-year median of 22.70 and 39.4% above the Healthcare Providers & Services industry median of 15.91. Shalby's overall GF Score™ is 86/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Shalby (NSE:SHALBY), the current EV-to-EBIT is 22.17 as of Aug. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shalby (NSE:SHALBY) Overvalued in 2026?
Based on GuruFocus' analysis, Shalby stock appears to be undervalued.
The current stock price of ₹154.03 is trading 41.2% below its estimated GF Value™ of ₹261.99.
GuruFocus considers Shalby to be Possible Value Trap.
Key valuation signals for NSE:SHALBY:
EV-to-EBIT: 22.17 (near median its 10-year median of 22.70)
GF Value™: ₹261.99 vs. price of ₹154.03 (41.2% below fair value)
Industry Position: 39.4% above the Healthcare Providers & Services median (#321 of 476)
No single metric tells the full story. See the NSE:SHALBY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shalby Ltd operates a chain of multispecialty hospitals. It is engaged in setting up and managing hospitals and medical diagnostic services. The hospitals offer healthcare services to patients in various areas of specialization such as Cardiology, Emergency Medicine, Gastroenterology Surgery, Arthroscopy Sports Injury, Infectious Diseases, Oncology, and others. The activities are mainly conducted only in India. Revenue mainly comprises fees charged for inpatient and outpatient hospital services. Services include charges for accommodation, medical professional services, equipment, radiology, laboratory, and pharmaceutical goods used in treatments given to Patients.
86GF Score
Get the complete analysis for NSE:SHALBY
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:SHALBY has been successfully added to your 
